RANITIDINE HYDROCHLORIDE

RANITIDINE HYDROCHLORIDE was reported 54188 times

RANITIDINE HYDROCHLORIDE is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 COMPUTERISED TOMOGRAM THORAX 26 0.4333
1 JUNCTIONAL ECTOPIC TACHYCARDIA 20 0.3448
2 SYNOVIAL FLUID ANALYSIS 25 0.2874
3 HAEMORRHAGE FOETAL 15 0.2830
4 HYPOCHOLESTEROLAEMIA 96 0.2720
5 HEPATIC ENZYME 39 0.2617
6 NASAL CAVITY CANCER 170 0.1854
7 FORAMEN MAGNUM STENOSIS 13 0.1429
8 TEMPERATURE REGULATION DISORDER 312 0.1399
9 BLADDER CANCER STAGE I, WITH CANCER IN SITU 30 0.1389
10 NEOPLASM OF APPENDIX 15 0.1327
11 OSTEOPOROSIS POSTMENOPAUSAL 19 0.1275
12 FOETAL ANAEMIA 15 0.1145
13 SINOBRONCHITIS 17 0.1141
14 SMALL INTESTINE CARCINOMA 254 0.1138
15 COLORECTAL CANCER 5102 0.1068
16 AIRWAY REMODELLING 13 0.1048
17 RENAL CANCER 4846 0.1016
18 OESOPHAGEAL CARCINOMA 2998 0.1010
19 HEPATIC CANCER 2343 0.0974
20 GALLBLADDER CANCER 136 0.0926
21 GASTRIC CANCER 2321 0.0915
22 GASTROINTESTINAL CARCINOMA 810 0.0891
23 PROSTATE CANCER 7126 0.0885
24 BLADDER CANCER 5173 0.0878
25 BREAST CANCER 7734 0.0829
26 FACET JOINT SYNDROME 270 0.0828
27 APPENDIX CANCER 76 0.0815
28 THROAT CANCER 329 0.0777
29 CARBUNCLE 22 0.0777
30 PANCREATIC CARCINOMA 2244 0.0776
31 PARANASAL SINUS INFLAMMATION 17 0.0766
32 PERIPHERAL VENOUS DISEASE 310 0.0758
33 OVERLAP SYNDROME 51 0.0729
34 LUPUS VULGARIS 91 0.0722
35 OESOPHAGEAL POLYP 13 0.0688
36 BREAST CANCER STAGE III 428 0.0660
37 BLEPHAROSPASM 414 0.0657
38 URETHRAL CANCER 14 0.0648
39 RENAL CANCER STAGE I 169 0.0645
40 SCHIZOAFFECTIVE DISORDER 113 0.0633
41 LUNG CARCINOMA CELL TYPE UNSPECIFIED STAGE II 29 0.0629
42 LUNG CARCINOMA CELL TYPE UNSPECIFIED STAGE I 60 0.0626
43 COLORECTAL CANCER STAGE I 126 0.0601
44 RENAL CANCER STAGE II 109 0.0600
45 RENAL CANCER STAGE III 110 0.0598
46 TENOSYNOVITIS STENOSANS 33 0.0592
47 BRONCHOPULMONARY ASPERGILLOSIS ALLERGIC 54 0.0583
48 TESTIS CANCER 227 0.0580
49 CHILD ABUSE 15 0.0579
50 NAIL AVULSION 13 0.0578
51 PERIPHERAL NERVE LESION 19 0.0576
52 ILIOTIBIAL BAND SYNDROME 13 0.0575
53 SINUS RHYTHM 25 0.0573
54 RHEUMATIC FEVER 254 0.0569
55 RADIAL NERVE PALSY 20 0.0567
56 ADRENAL GLAND CANCER 22 0.0566
57 ONYCHOMADESIS 237 0.0564
58 FOOD ALLERGY 429 0.0555
59 CERVIX CARCINOMA 217 0.0555
60 COMPUTERISED TOMOGRAM THORAX ABNORMAL 38 0.0553
61 BLADDER CANCER STAGE II 89 0.0552
62 ANTICHOLINERGIC SYNDROME 88 0.0552
63 HAEMATOLOGICAL MALIGNANCY 153 0.0537
64 PROSTATE CANCER STAGE I 205 0.0535
65 REVERSIBLE AIRWAYS OBSTRUCTION 27 0.0531
66 NASAL TURBINATE HYPERTROPHY 20 0.0531
67 BREAST CANCER STAGE II 432 0.0519
68 DISLOCATION OF VERTEBRA 118 0.0517
69 FOETAL DEATH 257 0.0495
70 THYROID CANCER 590 0.0490
71 BREAST CANCER STAGE I 451 0.0486
72 LARYNGEAL CANCER 54 0.0485
73 BURSITIS 585 0.0482
74 UTERINE CANCER 385 0.0479
75 LUNG NEOPLASM MALIGNANT 1963 0.0477
76 COLORECTAL CANCER STAGE II 134 0.0476
77 COLORECTAL CANCER STAGE III 239 0.0474
78 BLADDER CANCER STAGE III 57 0.0471
79 HEPATIC CANCER STAGE I 18 0.0469
80 NASOPHARYNGEAL CANCER 12 0.0458
81 PROSTATE CANCER STAGE II 139 0.0450
82 LUNG CARCINOMA CELL TYPE UNSPECIFIED STAGE III 38 0.0450
83 RETINITIS 74 0.0428
84 GASTRIC CANCER STAGE I 44 0.0417
85 NEOPLASM MALIGNANT 2749 0.0411
86 BRAIN NEOPLASM MALIGNANT 184 0.0411
87 CARCINOID TUMOUR 30 0.0403
88 BONE CANCER 175 0.0402
89 COLORECTAL CANCER STAGE IV 185 0.0401
90 BLADDER CANCER STAGE IV 67 0.0400
91 SYNOVIAL DISORDER 18 0.0396
92 PROSTATE CANCER STAGE III 104 0.0394
93 GASTRIC CANCER STAGE III 32 0.0391
94 VERTEBRAL LESION 20 0.0390
95 GASTRIC CANCER STAGE II 29 0.0387
96 TONGUE NEOPLASM MALIGNANT STAGE UNSPECIFIED 65 0.0386
97 TONSIL CANCER 31 0.0385
98 DEEP VEIN THROMBOSIS POSTOPERATIVE 75 0.0374
99 PNEUMOCOCCAL INFECTION 22 0.0372
100 ONYCHOMYCOSIS 159 0.0362
101 ANTI-CYCLIC CITRULLINATED PEPTIDE ANTIBODY POSITIVE 259 0.0361
102 DUODENAL ULCER PERFORATION 268 0.0360
103 HEPATIC CANCER STAGE III 16 0.0359
104 HEPATIC CANCER STAGE II 14 0.0355
105 PATELLOFEMORAL PAIN SYNDROME 18 0.0350
106 EPIDURAL LIPOMATOSIS 12 0.0349
107 FOLLICULITIS 359 0.0342
108 BREAST CANCER STAGE IV 97 0.0342
109 X-RAY ABNORMAL 61 0.0341
110 ANAL CANCER 33 0.0340
111 SUBCUTANEOUS DRUG ABSORPTION IMPAIRED 19 0.0339
112 VULVAL CANCER 20 0.0338
113 COELIAC DISEASE 330 0.0336
114 PROSTATE CANCER STAGE IV 118 0.0333
115 LUNG CARCINOMA CELL TYPE UNSPECIFIED STAGE IV 111 0.0329
116 TOTAL LUNG CAPACITY DECREASED 51 0.0319
117 RENAL CANCER STAGE IV 87 0.0316
118 OVARIAN CANCER 287 0.0311
119 HEPATIC CANCER STAGE IV 111 0.0300
120 MUSCLE INJURY 248 0.0299
121 PEMPHIGUS 370 0.0296
122 WRIST DEFORMITY 18 0.0293
123 MONOCLONAL IMMUNOGLOBULIN PRESENT 22 0.0289
124 IMMUNODEFICIENCY 428 0.0287
125 PANCREATIC CARCINOMA STAGE III 20 0.0285
126 SKIN CANCER 613 0.0284
127 PROSTATIC DISORDER 157 0.0284
128 PANCREATIC CARCINOMA STAGE I 13 0.0279
129 PLEURITIC PAIN 77 0.0279
130 URETERIC CANCER 11 0.0274
131 JOINT RANGE OF MOTION DECREASED 363 0.0270
132 ADJUSTMENT DISORDER WITH DEPRESSED MOOD 56 0.0270
133 MYOFASCIAL PAIN SYNDROME 19 0.0267
134 LIP DRY 242 0.0266
135 INFUSION SITE REACTION 79 0.0264
136 SALIVARY GLAND CANCER 13 0.0264
137 COLON CANCER 391 0.0262
138 INJURY 1787 0.0254
139 NAIL DISORDER 221 0.0252
140 WOUND INFECTION 275 0.0251
141 BONE CANCER METASTATIC 13 0.0246
142 NEUROENDOCRINE CARCINOMA 17 0.0246
143 SYNOVITIS 442 0.0245
144 C-REACTIVE PROTEIN ABNORMAL 157 0.0245
145 PRESCRIBED OVERDOSE 473 0.0244
146 BLADDER MASS 12 0.0242
147 GASTRIC CANCER STAGE IV 52 0.0242
148 PERICARDITIS 396 0.0235
149 DEFORMITY 217 0.0232
150 BRAIN CANCER METASTATIC 16 0.0231
151 PORPHYRIA ACUTE 33 0.0230
152 HYPERCHOLESTEROLAEMIA 217 0.0225
153 LIVE BIRTH 188 0.0225
154 LUNG OPACITY 59 0.0224
155 SWOLLEN JOINT COUNT INCREASED 71 0.0222
156 FINGER DEFORMITY 107 0.0221
157 PANCREATIC CARCINOMA STAGE II 14 0.0219
158 BILE DUCT CANCER 26 0.0218
159 ALLERGY TO CHEMICALS 27 0.0217
160 DYSPLASIA 26 0.0217
161 CONTRAINDICATED PRODUCT ADMINISTERED 656 0.0216
162 BONE EROSION 75 0.0212
163 PANCREATIC CARCINOMA STAGE IV 66 0.0209
164 LYMPHOCYTIC INFILTRATION 21 0.0208
165 HELICOBACTER INFECTION 212 0.0206
166 TASTE DISORDER 415 0.0204
167 AMPHETAMINES POSITIVE 15 0.0200
168 SOMATIC SYMPTOM DISORDER 21 0.0194
169 DEFAECATION DISORDER 13 0.0194
170 HEAD AND NECK CANCER 13 0.0192
171 SCLERITIS 30 0.0187
172 HAND DEFORMITY 245 0.0187
173 BACK INJURY 199 0.0183
174 OBESITY 287 0.0180
175 PRECANCEROUS CONDITION 12 0.0179
176 C-REACTIVE PROTEIN 16 0.0173
177 IRRITABLE BOWEL SYNDROME 359 0.0167
178 GRIP STRENGTH DECREASED 141 0.0160
179 LEUKAEMIA 149 0.0158
180 GLOSSODYNIA 341 0.0152
181 WOUND 424 0.0152
182 HYPOTHALAMO-PITUITARY DISORDER 22 0.0151
183 MULTIPLE DRUG THERAPY 11 0.0146
184 INTRADUCTAL PROLIFERATIVE BREAST LESION 18 0.0144
185 EXOSTOSIS 130 0.0142
186 GASTROINTESTINAL STROMAL TUMOUR 37 0.0139
187 VITAMIN B12 DECREASED 40 0.0139
188 RHEUMATOID FACTOR POSITIVE 80 0.0138
189 BREAST CALCIFICATIONS 11 0.0138
190 PRODUCT LABEL CONFUSION 80 0.0137
191 TRANSITIONAL CELL CARCINOMA 17 0.0131
192 BRAIN NEOPLASM 117 0.0127
193 FIBROMYALGIA 306 0.0126
194 NORMAL NEWBORN 68 0.0125
195 CREPITATIONS 37 0.0124
196 RECTAL CANCER 38 0.0124
197 EPILEPSY 371 0.0121
198 INFUSION RELATED REACTION 790 0.0119
199 PERSONALITY DISORDER 31 0.0118
200 ENDOCRINE OPHTHALMOPATHY 10 0.0115
201 HEPATIC ENZYME INCREASED 772 0.0113
202 TYPE 2 DIABETES MELLITUS 379 0.0112
203 RED BLOOD CELL SEDIMENTATION RATE INCREASED 124 0.0112
204 C-REACTIVE PROTEIN INCREASED 405 0.0111
205 RESTRICTIVE PULMONARY DISEASE 13 0.0111
206 ANTINUCLEAR ANTIBODY POSITIVE 36 0.0111
207 LYMPHOMA 171 0.0111
208 UPPER RESPIRATORY TRACT INFECTION 507 0.0110
209 EXPOSURE DURING PREGNANCY 679 0.0109
210 RHEUMATOID NODULE 29 0.0105
211 SYSTEMIC LUPUS ERYTHEMATOSUS 373 0.0105
212 NIGHT SWEATS 332 0.0103
213 NASAL SEPTUM DEVIATION 20 0.0102
214 LIVER INJURY 251 0.0102
215 IMPAIRED HEALING 335 0.0102
216 PSORIATIC ARTHROPATHY 406 0.0100
217 RALES 58 0.0100
218 CUSHINGOID 32 0.0100
219 ULCER HAEMORRHAGE 66 0.0097
220 RENAL MASS 20 0.0097
221 ANHEDONIA 255 0.0097
222 LOSS OF EMPLOYMENT 29 0.0096
223 OSTEOSCLEROSIS 15 0.0095
224 BLADDER NEOPLASM 16 0.0094
225 GASTROOESOPHAGEAL REFLUX DISEASE 745 0.0092
226 ENDOMETRIAL CANCER 20 0.0091
227 TENOSYNOVITIS 25 0.0091
228 ATELECTASIS 85 0.0088
229 EFFUSION 12 0.0088
230 ANXIETY DISORDER 29 0.0087
231 SYNOVIAL CYST 40 0.0087
232 BRONCHIECTASIS 58 0.0086
233 REBOUND ACID HYPERSECRETION 26 0.0086
234 LIVER FUNCTION TEST INCREASED 183 0.0085
235 COMPLICATIONS OF TRANSPLANTED KIDNEY 19 0.0084
236 HAEMORRHAGE IN PREGNANCY 12 0.0084
237 RASH ERYTHEMATOUS 392 0.0082
238 OSTEOARTHRITIS 347 0.0082
239 FIBROSIS 25 0.0081
240 DRUG TOLERANCE 40 0.0079
241 SCIATICA 125 0.0078
242 LOWER RESPIRATORY TRACT INFECTION 349 0.0077
243 OBSTRUCTIVE AIRWAYS DISORDER 85 0.0076
244 SPUTUM DISCOLOURED 72 0.0076
245 GAIT INABILITY 253 0.0076
246 THERAPEUTIC PRODUCT EFFECT DECREASED 338 0.0075
247 DRUG LEVEL INCREASED 124 0.0075
248 DRUG SCREEN POSITIVE 59 0.0075
249 DIASTOLIC DYSFUNCTION 23 0.0074
250 CHOLANGIOCARCINOMA 11 0.0074
251 BLOOD CHOLESTEROL INCREASED 344 0.0074
252 DRUG INTOLERANCE 712 0.0074
253 RENAL CELL CARCINOMA 36 0.0074
254 PULMONARY FIBROSIS 139 0.0072
255 DYSAESTHESIA 22 0.0072
256 RHEUMATOID ARTHRITIS 808 0.0071
257 NEUROENDOCRINE TUMOUR 10 0.0071
258 LUPUS-LIKE SYNDROME 64 0.0071
259 WHEEZING 417 0.0070
260 CHONDROPATHY 19 0.0070
261 JOINT EFFUSION 48 0.0070
262 LUNG DISORDER 338 0.0069
263 DYSLIPIDAEMIA 35 0.0069
264 CARTILAGE INJURY 17 0.0069
265 DRUG SCREEN FALSE POSITIVE 19 0.0069
266 TREATMENT FAILURE 568 0.0068
267 FLUID RETENTION 347 0.0068
268 NEPHRECTOMY 10 0.0067
269 PUSTULAR PSORIASIS 23 0.0067
270 AUTOIMMUNE DISORDER 65 0.0067
271 ATRIAL TACHYCARDIA 14 0.0067
272 ASPIRATION 73 0.0067
273 JOINT SWELLING 774 0.0064
274 LYMPHOEDEMA 44 0.0064
275 MUSCULOSKELETAL PAIN 333 0.0063
276 BLOOD CALCIUM INCREASED 55 0.0063
277 INVASIVE DUCTAL BREAST CARCINOMA 17 0.0062
278 BREAST CANCER FEMALE 166 0.0062
279 TRANSPLANT DYSFUNCTION 11 0.0062
280 DECREASED IMMUNE RESPONSIVENESS 60 0.0061
281 CHRONIC LYMPHOCYTIC LEUKAEMIA 29 0.0061
282 ADVERSE REACTION 81 0.0061
283 INFLAMMATION 302 0.0058
284 CONGENITAL ANOMALY 45 0.0058
285 CERVICAL VERTEBRAL FRACTURE 20 0.0058
286 BLOOD CREATININE ABNORMAL 20 0.0058
287 PATHOLOGICAL FRACTURE 29 0.0057
288 DRUG TOLERANCE DECREASED 16 0.0057
289 NEPHROPATHY 53 0.0057
290 FACIAL PARESIS 20 0.0056
291 END STAGE RENAL DISEASE 103 0.0056
292 RENAL CYST 44 0.0055
293 DIABETIC NEPHROPATHY 12 0.0054
294 BLISTER 306 0.0054
295 ARTHROPATHY 299 0.0054
296 ASTHMA 608 0.0054
297 RECALLED PRODUCT ADMINISTERED 51 0.0053
298 DRY MOUTH 433 0.0053
299 FLANK PAIN 50 0.0053
300 CHRONIC KIDNEY DISEASE 404 0.0053
301 SLEEP DISORDER DUE TO GENERAL MEDICAL CONDITION, INSOMNIA TYPE 34 0.0052
302 RENAL NEOPLASM 11 0.0052
303 STOMATITIS 314 0.0052
304 INCORRECT DRUG ADMINISTRATION DURATION 143 0.0051
305 PERIODONTITIS 11 0.0051
306 OVERWEIGHT 27 0.0050
307 MATERNAL EXPOSURE DURING PREGNANCY 442 0.0050
308 JOINT STIFFNESS 130 0.0050
309 PREMATURE LABOUR 28 0.0049
310 PRESCRIBED UNDERDOSE 98 0.0049
311 JUVENILE IDIOPATHIC ARTHRITIS 12 0.0049
312 ILL-DEFINED DISORDER 297 0.0049
313 MIGRAINE 460 0.0048
314 SLEEP DISORDER 338 0.0048
315 STUPOR 15 0.0047
316 COLITIS MICROSCOPIC 22 0.0046
317 HEPATIC STEATOSIS 86 0.0046
318 FORCED EXPIRATORY VOLUME DECREASED 13 0.0046
319 LUNG CANCER METASTATIC 13 0.0045
320 ADENOCARCINOMA 10 0.0045
321 B-CELL LYMPHOMA 15 0.0044
322 TENDERNESS 46 0.0044
323 MENISCUS INJURY 27 0.0044
324 HUMERUS FRACTURE 21 0.0044
325 EYELID DISORDER 10 0.0043
326 FOOT DEFORMITY 48 0.0043
327 DRUG-INDUCED LIVER INJURY 135 0.0043
328 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 304 0.0043
329 INTENTIONAL PRODUCT MISUSE 372 0.0042
330 PULMONARY MASS 63 0.0042
331 HYPERTENSION 894 0.0042
332 RESPIRATORY SYMPTOM 12 0.0042
333 HEPATIC CIRRHOSIS 79 0.0042
334 POLYNEUROPATHY 50 0.0042
335 KIDNEY TRANSPLANT REJECTION 20 0.0042
336 GASTROINTESTINAL TOXICITY 20 0.0042
337 PRODUCT USE ISSUE 781 0.0042
338 SWELLING 386 0.0041
339 SPINAL OSTEOARTHRITIS 36 0.0041
340 ELECTROCARDIOGRAM QT PROLONGED 146 0.0041
341 MICTURITION DISORDER 14 0.0040
342 HYPERSENSITIVITY 747 0.0040
343 EXERCISE TOLERANCE DECREASED 23 0.0040
344 HYPOVENTILATION 13 0.0040
345 LOWER LIMB FRACTURE 76 0.0040
346 EYE INJURY 12 0.0039
347 GASTROINTESTINAL DISORDER 351 0.0039
348 GENERAL PHYSICAL HEALTH DETERIORATION 452 0.0039
349 MONOCYTE COUNT INCREASED 14 0.0039
350 BLOOD TEST ABNORMAL 54 0.0038
351 HYPERHIDROSIS 495 0.0038
352 BLOOD PRESSURE INADEQUATELY CONTROLLED 23 0.0038
353 LIVER DISORDER 169 0.0038
354 WALKING AID USER 25 0.0038
355 EAR PAIN 73 0.0038
356 BLOOD PRESSURE DIASTOLIC INCREASED 17 0.0037
357 THROMBOCYTOPENIA 407 0.0036
358 PURPURA 32 0.0036
359 INCORRECT ROUTE OF PRODUCT ADMINISTRATION 62 0.0036
360 SQUAMOUS CELL CARCINOMA 34 0.0036
361 DYSPEPSIA 351 0.0036
362 UTERINE LEIOMYOMA 26 0.0036
363 HEPATITIS 91 0.0036
364 MOUTH HAEMORRHAGE 26 0.0035
365 NODULE 46 0.0035
366 RASH VESICULAR 17 0.0035
367 POLYP 23 0.0035
368 GRANULOCYTOPENIA 20 0.0035
369 REGURGITATION 12 0.0035
370 SLEEP DISORDER DUE TO A GENERAL MEDICAL CONDITION 59 0.0035
371 ULCER 55 0.0035
372 MEMORY IMPAIRMENT 473 0.0034
373 HYPOXIA 120 0.0034
374 PULMONARY TOXICITY 24 0.0034
375 RESPIRATORY DEPRESSION 41 0.0033
376 BLOOD CULTURE POSITIVE 10 0.0033
377 NECK PAIN 186 0.0033
378 PARAESTHESIA 523 0.0033
379 INCORRECT PRODUCT ADMINISTRATION DURATION 72 0.0033
380 LARGE INTESTINE POLYP 23 0.0033
381 PROSTATOMEGALY 13 0.0033
382 ABDOMINAL PAIN UPPER 681 0.0033
383 HYPERTRANSAMINASAEMIA 23 0.0033
384 TENSION HEADACHE 14 0.0033
385 CHRONIC MYELOID LEUKAEMIA 15 0.0032
386 CONJUNCTIVITIS 60 0.0032
387 CHRONIC SINUSITIS 12 0.0032
388 MATERNAL EXPOSURE TIMING UNSPECIFIED 12 0.0032
389 OSTEOPOROSIS 131 0.0032
390 GASTROINTESTINAL MOTILITY DISORDER 17 0.0032
391 PHYSICAL DISABILITY 14 0.0032
392 NOCTURIA 38 0.0031
393 INTENTIONAL PRODUCT USE ISSUE 274 0.0031
394 GASTROINTESTINAL INFECTION 28 0.0031
395 OESOPHAGEAL DISORDER 12 0.0031
396 SENSATION OF FOREIGN BODY 26 0.0031
397 MALIGNANT MELANOMA 41 0.0031
398 NEPHROGENIC ANAEMIA 14 0.0030
399 RESPIRATORY DISORDER 90 0.0030
400 GASTRITIS 79 0.0030
401 PERIPHERAL SWELLING 461 0.0030
402 MOBILITY DECREASED 215 0.0030
403 DISABILITY 59 0.0030
404 BREAST MASS 20 0.0030
405 HYPOAESTHESIA 445 0.0030
406 ANAPHYLACTOID REACTION 12 0.0029
407 VITAMIN D DEFICIENCY 28 0.0029
408 ABDOMINAL DISCOMFORT 476 0.0028
409 DEPRESSIVE SYMPTOM 10 0.0028
410 SUPRAVENTRICULAR TACHYCARDIA 27 0.0028
411 MUSCULOSKELETAL STIFFNESS 245 0.0028
412 TRANSAMINASES INCREASED 62 0.0028
413 DISCOMFORT 170 0.0028
414 MUSCLE STRAIN 24 0.0028
415 OSTEOPENIA 42 0.0028
416 HYPERLIPIDAEMIA 33 0.0028
417 TUBULOINTERSTITIAL NEPHRITIS 51 0.0027
418 LEUKOPENIA 136 0.0027
419 FREQUENT BOWEL MOVEMENTS 73 0.0027
420 BLOOD IRON DECREASED 32 0.0027
421 INFECTION 389 0.0027
422 PRODUCT QUALITY ISSUE 365 0.0027
423 URTICARIA 448 0.0027
424 PSORIASIS 348 0.0027
425 FOETAL GROWTH RESTRICTION 16 0.0026
426 GROIN PAIN 23 0.0026
427 TENDON DISORDER 17 0.0026
428 OESOPHAGEAL ULCER 10 0.0026
429 PAIN 1585 0.0026
430 RETCHING 55 0.0026
431 INJECTION SITE REACTION 176 0.0026
432 DUODENAL ULCER 18 0.0025
433 HAEMOPTYSIS 71 0.0025
434 PHLEBITIS 13 0.0025
435 BODY HEIGHT DECREASED 27 0.0025
436 STREPTOCOCCAL INFECTION 14 0.0025
437 DIVERTICULUM INTESTINAL 11 0.0025
438 CEREBRAL ATROPHY 10 0.0025
439 PLASMA CELL MYELOMA 97 0.0025
440 BONE DENSITY DECREASED 77 0.0025
441 SCAR 42 0.0025
442 CONSTIPATION 534 0.0024
443 ACUTE GENERALISED EXANTHEMATOUS PUSTULOSIS 19 0.0024
444 SUSPECTED OFF LABEL USE 11 0.0024
445 IMPAIRED QUALITY OF LIFE 35 0.0024
446 CONFUSIONAL STATE 393 0.0024
447 URINE ABNORMALITY 11 0.0024
448 CYST 30 0.0024
449 RASH 1052 0.0024
450 HAEMOGLOBIN INCREASED 11 0.0024
451 PYREXIA 829 0.0024
452 MEDICATION ERROR 132 0.0024
453 VISUAL FIELD DEFECT 17 0.0024
454 PSEUDOMONAS INFECTION 20 0.0023
455 ERYTHEMA 478 0.0023
456 SKIN ULCER 60 0.0023
457 METASTATIC NEOPLASM 10 0.0023
458 BLADDER DISORDER 23 0.0023
459 UNDERDOSE 167 0.0023
460 DELIRIUM 79 0.0023
461 CHOLECYSTECTOMY 26 0.0023
462 MOVEMENT DISORDER 73 0.0023
463 HYDRONEPHROSIS 17 0.0023
464 PHARYNGOLARYNGEAL PAIN 12 0.0023
465 OVERDOSE 486 0.0023
466 TOXIC EPIDERMAL NECROLYSIS 34 0.0022
467 IRON DEFICIENCY 10 0.0022
468 VITAMIN D DECREASED 19 0.0022
469 THERAPY NON-RESPONDER 99 0.0022
470 EMOTIONAL DISTRESS 263 0.0022
471 RENAL PAIN 23 0.0022
472 BREAST PAIN 23 0.0022
473 BACK PAIN 498 0.0021
474 BODY TEMPERATURE DECREASED 21 0.0021
475 BENIGN PROSTATIC HYPERPLASIA 11 0.0021
476 MUSCULAR WEAKNESS 242 0.0021
477 SKIN LACERATION 23 0.0021
478 GASTRIC ULCER 40 0.0021
479 MUSCLE SPASMS 386 0.0021
480 BLOOD LACTIC ACID INCREASED 11 0.0021
481 QUALITY OF LIFE DECREASED 28 0.0021
482 STEVENS-JOHNSON SYNDROME 46 0.0021
483 PHOTOPSIA 13 0.0021
484 BASAL CELL CARCINOMA 32 0.0020
485 MULTIPLE ALLERGIES 16 0.0020
486 HYPERCHLORHYDRIA 12 0.0020
487 OESOPHAGITIS 22 0.0020
488 DEPRESSION 450 0.0020
489 NASOPHARYNGITIS 360 0.0020
490 DIVERTICULITIS 54 0.0019
491 ABDOMINAL DISTENSION 203 0.0019
492 WEIGHT INCREASED 434 0.0019
493 WRONG PRODUCT ADMINISTERED 13 0.0019
494 SWELLING OF EYELID 12 0.0019
495 MYOSITIS 17 0.0019
496 HYPOPHOSPHATAEMIA 14 0.0019
497 JOINT DISLOCATION 20 0.0019
498 ANAPHYLACTIC SHOCK 48 0.0019
499 HIATUS HERNIA 24 0.0019
500 DRUG INTERACTION 293 0.0018
501 ANAPHYLACTIC REACTION 102 0.0018
502 SEASONAL ALLERGY 26 0.0018
503 ORAL CANDIDIASIS 24 0.0018
504 LIGAMENT SPRAIN 18 0.0018
505 PRODUCT USE IN UNAPPROVED INDICATION 449 0.0018
506 LYMPHOCYTE COUNT DECREASED 32 0.0018
507 PHOTOPHOBIA 34 0.0018
508 CHOLELITHIASIS 59 0.0018
509 FEELING JITTERY 34 0.0018
510 BREAST CANCER METASTATIC 19 0.0018
511 HEADACHE 1107 0.0018
512 ACCIDENTAL EXPOSURE TO PRODUCT BY CHILD 12 0.0018
513 ABNORMAL LOSS OF WEIGHT 12 0.0018
514 SINUSITIS 178 0.0017
515 CONTUSION 167 0.0017
516 MOUTH SWELLING 10 0.0017
517 BLOOD UREA INCREASED 29 0.0017
518 IMPAIRED WORK ABILITY 37 0.0017
519 OEDEMA PERIPHERAL 210 0.0017
520 MUCOSAL INFLAMMATION 45 0.0017
521 ROTATOR CUFF SYNDROME 22 0.0017
522 ANGINA PECTORIS 49 0.0017
523 RASH MACULO-PAPULAR 38 0.0017
524 DYSPNOEA EXERTIONAL 64 0.0017
525 HIP ARTHROPLASTY 26 0.0017
526 OFF LABEL USE 1486 0.0017
527 FEELING HOT 104 0.0017
528 OEDEMA 92 0.0017
529 PROCEDURAL COMPLICATION 13 0.0017
530 FLATULENCE 96 0.0017
531 NEPHROPATHY TOXIC 19 0.0017
532 DIVERTICULUM 12 0.0017
533 WRONG DRUG ADMINISTERED 15 0.0017
534 RED BLOOD CELL COUNT DECREASED 48 0.0017
535 BLOOD CREATININE INCREASED 109 0.0017
536 DERMATITIS ALLERGIC 21 0.0017
537 VOMITING 784 0.0017
538 ACUTE KIDNEY INJURY 255 0.0017
539 DERMATITIS CONTACT 19 0.0017
540 HERNIA 32 0.0017
541 FAECES SOFT 12 0.0016
542 RENAL FAILURE 219 0.0016
543 HYPOCALCAEMIA 31 0.0016
544 DECREASED APPETITE 376 0.0016
545 EJECTION FRACTION DECREASED 25 0.0016
546 ANXIETY 457 0.0016
547 OCULAR DISCOMFORT 18 0.0016
548 GENERAL SYMPTOM 12 0.0016
549 RESPIRATION ABNORMAL 11 0.0016
550 PRODUCT PRESCRIBING ERROR 38 0.0016
551 ALOPECIA 313 0.0016
552 SKIN DISORDER 53 0.0016
553 AMNESIA 103 0.0016
554 BLOOD COUNT ABNORMAL 24 0.0016
555 ABDOMINAL PAIN 367 0.0016
556 DEFAECATION URGENCY 11 0.0016
557 PNEUMONIA ASPIRATION 39 0.0016
558 ANAL INCONTINENCE 14 0.0016
559 ERUCTATION 30 0.0015
560 INCOHERENT 10 0.0015
561 JOINT INJURY 33 0.0015
562 BLOOD PRESSURE SYSTOLIC INCREASED 30 0.0015
563 RECTAL HAEMORRHAGE 66 0.0015
564 ASTHENIA 577 0.0015
565 PETECHIAE 16 0.0015
566 PHARYNGEAL SWELLING 15 0.0015
567 ADVERSE EVENT 141 0.0015
568 RENAL INJURY 45 0.0015
569 LIMB INJURY 41 0.0015
570 ROAD TRAFFIC ACCIDENT 63 0.0015
571 BLOOD DISORDER 12 0.0015
572 MICTURITION URGENCY 17 0.0015
573 URINE OUTPUT DECREASED 13 0.0015
574 VISUAL IMPAIRMENT 184 0.0015
575 EAR INFECTION 39 0.0015
576 GLAUCOMA 28 0.0015
577 ALANINE AMINOTRANSFERASE INCREASED 89 0.0014
578 PULMONARY CONGESTION 19 0.0014
579 FOETAL EXPOSURE DURING PREGNANCY 117 0.0014
580 OROPHARYNGEAL DISCOMFORT 13 0.0014
581 HYPONATRAEMIA 81 0.0014
582 HEPATOTOXICITY 32 0.0014
583 ARTHRITIS 113 0.0014
584 PNEUMONIA 465 0.0014
585 OCULAR HYPERAEMIA 68 0.0014
586 BODY TEMPERATURE INCREASED 29 0.0014
587 PAPULE 10 0.0014
588 PLEURAL EFFUSION 86 0.0014
589 HAEMATOCRIT DECREASED 28 0.0014
590 HYPOKALAEMIA 65 0.0014
591 ANGIOEDEMA 62 0.0014
592 NEOPLASM 16 0.0014
593 BLOOD LACTATE DEHYDROGENASE INCREASED 22 0.0014
594 METASTASES TO LUNG 16 0.0014
595 HAEMORRHOIDS 27 0.0014
596 CONDITION AGGRAVATED 415 0.0014
597 HYPOMAGNESAEMIA 19 0.0014
598 RHINITIS 11 0.0014
599 LUNG INFILTRATION 12 0.0014
600 DYSPNOEA 768 0.0014
601 DIABETES MELLITUS INADEQUATE CONTROL 24 0.0014
602 URINARY RETENTION 45 0.0013
603 RASH PRURITIC 73 0.0013
604 DIZZINESS POSTURAL 13 0.0013
605 ARTHRALGIA 555 0.0013
606 PREMATURE BABY 40 0.0013
607 MITRAL VALVE INCOMPETENCE 15 0.0013
608 INCONTINENCE 14 0.0013
609 FULL BLOOD COUNT ABNORMAL 14 0.0013
610 DEVICE RELATED INFECTION 20 0.0013
611 PREGNANCY 26 0.0013
612 BRAIN INJURY 13 0.0013
613 PAIN IN EXTREMITY 382 0.0013
614 CHEST PAIN 240 0.0013
615 SWELLING FACE 84 0.0013
616 DYSURIA 47 0.0013
617 FURUNCLE 10 0.0013
618 COUGH 353 0.0013
619 LOW BIRTH WEIGHT BABY 10 0.0013
620 MALNUTRITION 14 0.0013
621 PANCREATITIS 66 0.0012
622 WEIGHT FLUCTUATION 13 0.0012
623 SENSORY LOSS 10 0.0012
624 EYE INFECTION 14 0.0012
625 INCORRECT DOSE ADMINISTERED 283 0.0012
626 HAEMATOMA 32 0.0012
627 CIRCULATORY COLLAPSE 21 0.0012
628 DYSSTASIA 36 0.0012
629 HAEMATURIA 42 0.0012
630 DIARRHOEA 789 0.0012
631 SMALL INTESTINAL OBSTRUCTION 15 0.0012
632 FATIGUE 947 0.0012
633 CYANOSIS 19 0.0012
634 DISSEMINATED INTRAVASCULAR COAGULATION 17 0.0012
635 IRON DEFICIENCY ANAEMIA 11 0.0012
636 INTERVERTEBRAL DISC PROTRUSION 26 0.0012
637 PRODUCT TASTE ABNORMAL 16 0.0012
638 ERYTHEMA MULTIFORME 11 0.0012
639 ANAEMIA 223 0.0012
640 INSOMNIA 311 0.0012
641 METASTASES TO CENTRAL NERVOUS SYSTEM 15 0.0012
642 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 55 0.0011
643 METASTASES TO LIVER 20 0.0011
644 MELAENA 25 0.0011
645 ASPARTATE AMINOTRANSFERASE INCREASED 60 0.0011
646 HEPATIC FUNCTION ABNORMAL 42 0.0011
647 DIZZINESS 560 0.0011
648 ELECTROLYTE IMBALANCE 13 0.0011
649 PALMAR-PLANTAR ERYTHRODYSAESTHESIA SYNDROME 26 0.0011
650 MALAISE 488 0.0011
651 GASTRIC DISORDER 38 0.0011
652 BACK DISORDER 18 0.0011
653 NAUSEA 875 0.0011
654 POLLAKIURIA 46 0.0011
655 INTERSTITIAL LUNG DISEASE 53 0.0011
656 ADVERSE DRUG REACTION 97 0.0011
657 INAPPROPRIATE ANTIDIURETIC HORMONE SECRETION 11 0.0011
658 CARPAL TUNNEL SYNDROME 15 0.0011
659 GALLBLADDER DISORDER 19 0.0011
660 LYMPHOPENIA 15 0.0011
661 DYSPHAGIA 100 0.0011
662 LIP SWELLING 35 0.0010
663 LYMPHADENOPATHY 37 0.0010
664 KNEE ARTHROPLASTY 22 0.0010
665 PHARYNGEAL OEDEMA 16 0.0010
666 RENAL IMPAIRMENT 87 0.0010
667 IMPAIRED GASTRIC EMPTYING 14 0.0010
668 PRODUCTIVE COUGH 49 0.0010
669 TACHYCARDIA 91 0.0010
670 DECREASED ACTIVITY 11 0.0010
671 RENAL TUBULAR NECROSIS 10 0.0010
672 WHITE BLOOD CELL COUNT INCREASED 39 0.0010
673 EPISTAXIS 76 0.0010
674 ECZEMA 53 0.0010
675 BACTERAEMIA 12 0.0010
676 NEUTROPHIL COUNT DECREASED 41 0.0010
677 DERMATITIS 21 0.0010
678 GASTROINTESTINAL PAIN 11 0.0010
679 FEBRILE NEUTROPENIA 66 0.0010
680 HALLUCINATION, VISUAL 21 0.0010
681 HEPATITIS C 12 0.0010
682 COMA 47 0.0010
683 TOOTH INFECTION 13 0.0010
684 HAEMOGLOBIN DECREASED 101 0.0010
685 DISTURBANCE IN ATTENTION 53 0.0010
686 DRUG INEFFECTIVE 1294 0.0010
687 BRONCHOSPASM 14 0.0010
688 OXYGEN SATURATION DECREASED 55 0.0010
689 FISTULA 11 0.0010
690 HEART RATE IRREGULAR 22 0.0010
691 CYSTITIS 31 0.0010
692 THROMBOSIS 78 0.0010
693 COVID-19 170 0.0010
694 CHEST DISCOMFORT 99 0.0010
695 MENTAL DISORDER 42 0.0010
696 BACTERIAL INFECTION 18 0.0010
697 RESPIRATORY TRACT INFECTION 25 0.0010
698 BLOOD SODIUM DECREASED 18 0.0010
699 GAIT DISTURBANCE 182 0.0009
700 BLOOD URINE PRESENT 18 0.0009
701 CORONARY ARTERY OCCLUSION 13 0.0009
702 GAMMA-GLUTAMYLTRANSFERASE INCREASED 21 0.0009
703 CLOSTRIDIUM DIFFICILE COLITIS 10 0.0009
704 NEPHROLITHIASIS 43 0.0009
705 RHABDOMYOLYSIS 39 0.0009
706 ANOREXIA 12 0.0009
707 UNRESPONSIVE TO STIMULI 24 0.0009
708 PRURITUS GENERALISED 20 0.0009
709 RENAL DISORDER 43 0.0009
710 VERTIGO 56 0.0009
711 BRONCHITIS 68 0.0009
712 KIDNEY INFECTION 18 0.0009
713 TREMOR 152 0.0009
714 URINARY INCONTINENCE 27 0.0009
715 CARDIAC FAILURE 73 0.0009
716 MUSCLE SPASTICITY 11 0.0009
717 CARDIOMEGALY 11 0.0009
718 FEEDING DISORDER 18 0.0009
719 PHARYNGITIS 11 0.0009
720 FALL 294 0.0009
721 DISORIENTATION 35 0.0009
722 SEPSIS 98 0.0009
723 COGNITIVE DISORDER 41 0.0009
724 FAECES DISCOLOURED 19 0.0009
725 EXPIRED PRODUCT ADMINISTERED 29 0.0009
726 ORAL HERPES 17 0.0009
727 OROPHARYNGEAL PAIN 80 0.0009
728 DRY EYE 43 0.0009
729 WEIGHT DECREASED 240 0.0009
730 CAESAREAN SECTION 10 0.0009
731 INFUSION SITE PAIN 11 0.0009
732 THROAT TIGHTNESS 23 0.0008
733 WHITE BLOOD CELL COUNT DECREASED 92 0.0008
734 PHOTOSENSITIVITY REACTION 14 0.0008
735 PLATELET COUNT INCREASED 11 0.0008
736 MYALGIA 143 0.0008
737 LUNG INFECTION 13 0.0008
738 HAEMATOCHEZIA 46 0.0008
739 SARS-COV-2 TEST POSITIVE 11 0.0008
740 DEPRESSED MOOD 44 0.0008
741 HYPERTHYROIDISM 12 0.0008
742 DIABETES MELLITUS 63 0.0008
743 RENAL FAILURE ACUTE 35 0.0008
744 PERITONITIS 17 0.0008
745 PNEUMOTHORAX 13 0.0008
746 ERECTILE DYSFUNCTION 21 0.0008
747 ASCITES 24 0.0008
748 RASH GENERALISED 21 0.0008
749 HYPERCALCAEMIA 10 0.0008
750 CARDIAC FAILURE CONGESTIVE 65 0.0008
751 ILEUS 10 0.0008
752 RASH MACULAR 28 0.0008
753 BLOOD POTASSIUM INCREASED 13 0.0008
754 CHROMATURIA 18 0.0008
755 COLD SWEAT 14 0.0008
756 DYSGEUSIA 59 0.0008
757 METASTASES TO BONE 13 0.0008
758 FEELING COLD 22 0.0008
759 PROTEINURIA 15 0.0008
760 CHOLESTASIS 15 0.0008
761 SKIN REACTION 11 0.0008
762 EYE PAIN 44 0.0008
763 PRURITUS 298 0.0008
764 FEMUR FRACTURE 24 0.0008
765 HOSPITALISATION 119 0.0008
766 BRADYCARDIA 41 0.0008
767 PELVIC PAIN 14 0.0008
768 SUBDURAL HAEMATOMA 11 0.0008
769 BONE PAIN 45 0.0008
770 PULMONARY HYPERTENSION 16 0.0008
771 HEPATIC FAILURE 23 0.0008
772 HALLUCINATION, AUDITORY 12 0.0008
773 AGRANULOCYTOSIS 14 0.0008
774 HAEMATEMESIS 19 0.0007
775 TREATMENT NONCOMPLIANCE 41 0.0007
776 URINARY TRACT INFECTION 127 0.0007
777 PAIN IN JAW 21 0.0007
778 CATARACT 44 0.0007
779 BLOOD TRIGLYCERIDES INCREASED 13 0.0007
780 LOSS OF CONSCIOUSNESS 94 0.0007
781 SLEEP APNOEA SYNDROME 14 0.0007
782 BLOOD PRESSURE INCREASED 112 0.0007
783 MULTIPLE SCLEROSIS 35 0.0007
784 RIB FRACTURE 15 0.0007
785 ECONOMIC PROBLEM 11 0.0007
786 SOMNOLENCE 146 0.0007
787 INSURANCE ISSUE 11 0.0007
788 CARDIO-RESPIRATORY ARREST 30 0.0007
789 DYSARTHRIA 27 0.0007
790 COORDINATION ABNORMAL 10 0.0007
791 MASS 10 0.0007
792 BONE DISORDER 13 0.0007
793 LETHARGY 41 0.0007
794 COLITIS 27 0.0007
795 MUSCULOSKELETAL CHEST PAIN 11 0.0007
796 DIALYSIS 10 0.0007
797 SWOLLEN TONGUE 22 0.0007
798 HYPOTENSION 141 0.0007
799 CHILLS 82 0.0007
800 MUSCULOSKELETAL DISCOMFORT 12 0.0007
801 PARAESTHESIA ORAL 10 0.0007
802 BONE MARROW FAILURE 14 0.0007
803 HYPOKINESIA 10 0.0007
804 GASTROENTERITIS 10 0.0007
805 EOSINOPHILIA 12 0.0007
806 RESTLESSNESS 25 0.0007
807 DEPRESSED LEVEL OF CONSCIOUSNESS 27 0.0007
808 MUSCLE TIGHTNESS 11 0.0007
809 HOT FLUSH 51 0.0007
810 INFLUENZA 75 0.0007
811 ISCHAEMIC STROKE 12 0.0007
812 FLUSHING 68 0.0007
813 MANIA 11 0.0007
814 CHOKING 13 0.0007
815 HEART RATE INCREASED 66 0.0007
816 BLOOD POTASSIUM DECREASED 20 0.0007
817 HYPOPHAGIA 17 0.0007
818 CORONARY ARTERY DISEASE 20 0.0007
819 EYE IRRITATION 38 0.0007
820 SKIN LESION 18 0.0007
821 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 36 0.0007
822 UPPER GASTROINTESTINAL HAEMORRHAGE 11 0.0007
823 POOR QUALITY SLEEP 14 0.0006
824 DYSPHONIA 38 0.0006
825 PERICARDIAL EFFUSION 15 0.0006
826 OSTEONECROSIS OF JAW 16 0.0006
827 BLOOD ALKALINE PHOSPHATASE INCREASED 16 0.0006
828 RHINORRHOEA 41 0.0006
829 VIRAL INFECTION 21 0.0006
830 HEART RATE DECREASED 22 0.0006
831 METABOLIC ACIDOSIS 20 0.0006
832 NEUTROPENIA 85 0.0006
833 EYE PRURITUS 21 0.0006
834 POST PROCEDURAL COMPLICATION 12 0.0006
835 ACUTE RESPIRATORY FAILURE 12 0.0006
836 SEPTIC SHOCK 27 0.0006
837 RESPIRATORY DISTRESS 17 0.0006
838 BLINDNESS 25 0.0006
839 BURNING SENSATION 43 0.0006
840 DEAFNESS 16 0.0006
841 LABORATORY TEST ABNORMAL 18 0.0006
842 GASTROENTERITIS VIRAL 11 0.0006
843 PANCYTOPENIA 34 0.0006
844 OSTEOMYELITIS 11 0.0006
845 DEHYDRATION 81 0.0006
846 DRUG EFFECT INCOMPLETE 22 0.0006
847 COAGULOPATHY 10 0.0006
848 IRRITABILITY 36 0.0006
849 ATRIAL FIBRILLATION 58 0.0006
850 CELLULITIS 30 0.0006
851 FACE OEDEMA 10 0.0006
852 THINKING ABNORMAL 11 0.0006
853 DRUG REACTION WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS 15 0.0006
854 PULMONARY OEDEMA 26 0.0006
855 ORAL PAIN 13 0.0006
856 PARANOIA 10 0.0006
857 THROAT IRRITATION 26 0.0006
858 MULTI-ORGAN FAILURE 10 0.0006
859 PANCREATITIS ACUTE 13 0.0006
860 STAPHYLOCOCCAL INFECTION 19 0.0006
861 ACCIDENTAL OVERDOSE 21 0.0006
862 SKIN DISCOLOURATION 26 0.0006
863 ACUTE RESPIRATORY DISTRESS SYNDROME 10 0.0006
864 PLATELET COUNT DECREASED 60 0.0006
865 HYPERSOMNIA 16 0.0006
866 JAUNDICE 15 0.0006
867 INTESTINAL OBSTRUCTION 21 0.0006
868 BLOOD CREATINE PHOSPHOKINASE INCREASED 16 0.0006
869 SINUS DISORDER 11 0.0006
870 BLOOD BILIRUBIN INCREASED 15 0.0006
871 DEEP VEIN THROMBOSIS 36 0.0006
872 LIVER FUNCTION TEST ABNORMAL 16 0.0005
873 RESTLESS LEGS SYNDROME 10 0.0005
874 CARDIAC ARREST 45 0.0005
875 RESPIRATORY ARREST 15 0.0005
876 ACUTE MYOCARDIAL INFARCTION 16 0.0005
877 CONVULSION 31 0.0005
878 BLOOD PRESSURE DECREASED 36 0.0005
879 HYPERKALAEMIA 19 0.0005
880 DYSKINESIA 22 0.0005
881 MENTAL STATUS CHANGES 15 0.0005
882 HERPES ZOSTER 31 0.0005
883 PALPITATIONS 62 0.0005
884 FRACTURE 10 0.0005
885 INTERNATIONAL NORMALISED RATIO INCREASED 15 0.0005
886 ILLNESS 54 0.0005
887 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 27 0.0005
888 EYE DISORDER 17 0.0005
889 SPEECH DISORDER 27 0.0005
890 NERVOUS SYSTEM DISORDER 16 0.0005
891 CARDIOVASCULAR DISORDER 13 0.0005
892 NEUROPATHY PERIPHERAL 48 0.0005
893 CLOSTRIDIUM DIFFICILE INFECTION 11 0.0005
894 TRANSIENT ISCHAEMIC ATTACK 17 0.0005
895 AGITATION 37 0.0005
896 CEREBRAL HAEMORRHAGE 18 0.0005
897 FEELING ABNORMAL 120 0.0005
898 BLOOD PRESSURE FLUCTUATION 12 0.0005
899 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 90 0.0005
900 LOCALISED INFECTION 12 0.0005
901 NASAL CONGESTION 29 0.0005
902 COLITIS ULCERATIVE 22 0.0005
903 SUICIDAL IDEATION 45 0.0005
904 ENCEPHALOPATHY 12 0.0005
905 OSTEONECROSIS 16 0.0005
906 INFLUENZA LIKE ILLNESS 40 0.0005
907 EYE SWELLING 18 0.0005
908 DRUG ABUSE 40 0.0005
909 FUNGAL INFECTION 16 0.0005
910 TINNITUS 22 0.0005
911 SURGERY 28 0.0005
912 WITHDRAWAL SYNDROME 20 0.0005
913 PSYCHOTIC DISORDER 14 0.0005
914 PULMONARY EMBOLISM 45 0.0005
915 MYELOSUPPRESSION 17 0.0005
916 HYPOTHYROIDISM 15 0.0005
917 ARRHYTHMIA 22 0.0005
918 DRUG EFFECT DECREASED 25 0.0005
919 APHASIA 14 0.0005
920 LACRIMATION INCREASED 14 0.0005
921 NEOPLASM PROGRESSION 16 0.0005
922 SYNCOPE 46 0.0005
923 BLOOD GLUCOSE DECREASED 22 0.0005
924 LIMB DISCOMFORT 14 0.0005
925 CEREBRAL INFARCTION 11 0.0004
926 RASH PAPULAR 10 0.0004
927 PAIN OF SKIN 12 0.0004
928 ABASIA 11 0.0004
929 HYPERGLYCAEMIA 16 0.0004
930 SHOCK 10 0.0004
931 DEATH 370 0.0004
932 CARDIAC DISORDER 40 0.0004
933 RESPIRATORY FAILURE 31 0.0004
934 NERVOUSNESS 22 0.0004
935 CRYING 15 0.0004
936 HYPOGLYCAEMIA 20 0.0004
937 PALLOR 11 0.0004
938 MYOCARDIAL INFARCTION 70 0.0004
939 MALIGNANT NEOPLASM PROGRESSION 41 0.0004
940 AGGRESSION 20 0.0004
941 BALANCE DISORDER 34 0.0004
942 ANGER 13 0.0004
943 GASTROINTESTINAL HAEMORRHAGE 32 0.0004
944 DRUG EXPOSURE DURING PREGNANCY 13 0.0004
945 PRODUCT SUBSTITUTION ISSUE 22 0.0004
946 SEIZURE 44 0.0004
947 MULTIPLE SCLEROSIS RELAPSE 26 0.0004
948 NEEDLE ISSUE 11 0.0004
949 PRODUCT DOSE OMISSION ISSUE 111 0.0004
950 NO ADVERSE EVENT 68 0.0004
951 FEAR 10 0.0004
952 EXTRA DOSE ADMINISTERED 15 0.0004
953 PNEUMONITIS 10 0.0004
954 HAEMORRHAGE 38 0.0004
955 VISUAL ACUITY REDUCED 12 0.0004
956 DISEASE RECURRENCE 17 0.0004
957 VISION BLURRED 49 0.0004
958 HEAD INJURY 11 0.0003
959 NIGHTMARE 12 0.0003
960 INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION 24 0.0003
961 PRODUCT DOSE OMISSION 22 0.0003
962 UNEVALUABLE EVENT 25 0.0003
963 THERAPEUTIC RESPONSE DECREASED 20 0.0003
964 DEPENDENCE 18 0.0003
965 ABNORMAL BEHAVIOUR 13 0.0003
966 HALLUCINATION 24 0.0003
967 THERAPEUTIC RESPONSE UNEXPECTED 14 0.0003
968 DRUG DEPENDENCE 50 0.0003
969 HIP FRACTURE 10 0.0003
970 ACNE 23 0.0003
971 PANIC ATTACK 11 0.0003
972 CEREBROVASCULAR ACCIDENT 50 0.0003
973 THERAPY CESSATION 15 0.0003
974 INJECTION SITE SWELLING 22 0.0003
975 HYPOACUSIS 12 0.0003
976 DRY SKIN 36 0.0003
977 INJECTION SITE BRUISING 21 0.0003
978 DISEASE PROGRESSION 31 0.0003
979 SKIN IRRITATION 12 0.0003
980 INJECTION SITE ERYTHEMA 32 0.0003
981 VAGINAL HAEMORRHAGE 11 0.0003
982 BLOOD GLUCOSE INCREASED 47 0.0002
983 DRUG DOSE OMISSION 40 0.0002
984 COMPLETED SUICIDE 20 0.0002
985 SKIN EXFOLIATION 20 0.0002
986 INJECTION SITE HAEMORRHAGE 18 0.0002
987 TOXICITY TO VARIOUS AGENTS 35 0.0002
988 THERAPY INTERRUPTED 13 0.0002
989 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 36 0.0002
990 INJECTION SITE PAIN 51 0.0002
991 INJECTION SITE PRURITUS 10 0.0001